In the realm of medical diagnostics, the landscape is rapidly evolving, driven by advancements in technology and the demand for faster, more accurate results. One of the most transformative developments in recent years has been the rise of point-of-care molecular diagnostics. This sector combines the precision of molecular biology with the convenience of rapid testing,... Continue Reading →
Emerging Markets the Next Frontier for Point of Care Molecular Diagnostics
The global point of care molecular diagnostics market is experiencing rapid growth, projected to expand from $2.0 billion in 2023 to $3.4 billion by 2028 at a compound annual growth rate of 10.6%. This surge is being driven by the rising incidence of infectious diseases, cancer, and other acute and chronic conditions worldwide. As healthcare... Continue Reading →
Point of Care Molecular Diagnostics: A Deep Dive into Market Growth and Trends
Point of Care Molecular Diagnostics Market in terms of revenue was estimated to be worth $2.0 billion in 2023 and is poised to reach $3.4 billion by 2028, growing at a CAGR of 10.6% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by increasing... Continue Reading →
The Future of Diagnostics: Point of Care Molecular Diagnostics Market
Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland) and bioMérieux SA (France) are the Major Players in the Point of Care Molecular Diagnostics Market
Comprehensive Overview of Point of Care Molecular Diagnostics Leading Players
A new report titled, “Global Point of Care Molecular Diagnostics Market”, has been added by MarketsandMarkets™ INC to its vast database of research reports. The Global Point of Care Molecular Diagnostics Market is poised to grow at a CAGR of 8.2% during the forecast period, 2021-2026. This intelligent study provides the definition, description, and the... Continue Reading →